MedTrace Logo

Mindfulness-based Illness Management Program for Schizophrenia

NCT01667601 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 449

Last updated 2019-12-18

No results posted yet for this study

Summary

Only a few intervention studies have also focused on changing patients' negative thoughts and feelings towards the illness and their relationship to the suffering caused by those thoughts, which is evidenced to empower psychosocial functioning and control of distressing thoughts in severe depression and psychotic disorders by using the Mindfulness-Based Stress Reduction program. This controlled trial is designed to test the effects of a mindfulness-based Illness management program (MBPP) for Chinese patients with schizophrenia on their symptom severity, illness insight and psychosocial functioning.

Conditions

Interventions

OTHER

Routine Care

Psychiatric outpatient care provided by the outpatient departments, e.g., medical consultation, brief education by psychiatric nurses and financial advices or referrals by social workers.

BEHAVIORAL

Mindfulness-based program

The program was based on the psychoeducation programs by Chien et al and Lehman et al, as well as the 8-session Mindfulness-Based Stress Reduction Program by Kabat-Zinn(1990).

BEHAVIORAL

Psychoeducation group

A 5-month patient psychoeducation group program (12 sessions) led by the research team will be provided.

Sponsors & Collaborators

  • Hospital Authority, Hong Kong

    collaborator OTHER_GOV

  • Jilin Medical College, China

    collaborator UNKNOWN

  • Taipei Medical University, Taiwan

    collaborator UNKNOWN

  • The Hong Kong Polytechnic University

    lead OTHER

Principal Investigators

  • Chien WT, PhD · The HK Polytechnic University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-31
Primary Completion
2016-06-30
Completion
2017-04-30

Countries

  • China
  • Hong Kong
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01667601 on ClinicalTrials.gov